18 research outputs found

    A study linking patient EHR data to external death data at Stanford Medicine

    Full text link
    This manuscript explores linking real-world patient data with external death data in the context of research Clinical Data Warehouses (r-CDWs). We specifically present the linking of Electronic Health Records (EHR) data for Stanford Health Care (SHC) patients and data from the Social Security Administration (SSA) Limited Access Death Master File (LADMF) made available by the US Department of Commerce's National Technical Information Service (NTIS). The data analysis framework presented in this manuscript extends prior approaches and is generalizable to linking any two cross-organizational real-world patient data sources. Electronic Health Record (EHR) data and NTIS LADMF are heavily used resources at other medical centers and we expect that the methods and learnings presented here will be valuable to others. Our findings suggest that strong linkages are incomplete and weak linkages are noisy i.e., there is no good linkage rule that provides coverage and accuracy. Furthermore, the best linkage rule for any two datasets is different from the best linkage rule for two other datasets i.e., there is no generalization of linkage rules. Finally, LADMF, a commonly used external death data resource for r-CDWs, has a significant gap in death data making it necessary for r-CDWs to seek out more than one external death data source. We anticipate that presentation of multiple linkages will make it hard to present the linkage outcome to the end user. This manuscript is a resource in support of Stanford Medicine STARR (STAnford medicine Research data Repository) r-CDWs. The data are stored and analyzed as PHI in our HIPAA-compliant data center and are used under research and development (R&D) activities of STARR IRB.Comment: 20 page

    American Family Cohort, a data resource description

    Full text link
    This manuscript is a research resource description and presents a large and novel Electronic Health Records (EHR) data resource, American Family Cohort (AFC). The AFC data is derived from Centers for Medicare and Medicaid Services (CMS) certified American Board of Family Medicine (ABFM) PRIME registry. The PRIME registry is the largest national Qualified Clinical Data Registry (QCDR) for Primary Care. The data is converted to a popular common data model, the Observational Health Data Sciences and Informatics (OHDSI) Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM). The resource presents approximately 90 million encounters for 7.5 million patients. All 100% of the patients present age, gender, and address information, and 73% report race. Nealy 93% of patients have lab data in LOINC, 86% have medication data in RxNorm, 93% have diagnosis in SNOWMED and ICD, 81% have procedures in HCPCS or CPT, and 61% have insurance information. The richness, breadth, and diversity of this research accessible and research ready data is expected to accelerate observational studies in many diverse areas. We expect this resource to facilitate research in many years to come

    Gradient Clogging in Depth Filtration

    Full text link
    We investigate clogging in depth filtration, in which a dirty fluid is ``cleaned'' by the trapping of dirt particles within the pore space during flow through a porous medium. This leads to a gradient percolation process which exhibits a power law distribution for the density of trapped particles at downstream distance x from the input. To achieve a non-pathological clogging (percolation) threshold, the system length L should scale no faster than a power of ln w, where w is the width. Non-trivial behavior for the permeability arises only in this extreme anisotropic geometry.Comment: 4 pages, 3 figures, RevTe

    Digital Health: Tracking Physiomes and Activity Using Wearable Biosensors Reveals Useful Health-Related Information

    No full text
    <div><p>A new wave of portable biosensors allows frequent measurement of health-related physiology. We investigated the use of these devices to monitor human physiological changes during various activities and their role in managing health and diagnosing and analyzing disease. By recording over 250,000 daily measurements for up to 43 individuals, we found personalized circadian differences in physiological parameters, replicating previous physiological findings. Interestingly, we found striking changes in particular environments, such as airline flights (decreased peripheral capillary oxygen saturation [SpO<sub>2</sub>] and increased radiation exposure). These events are associated with physiological macro-phenotypes such as fatigue, providing a strong association between reduced pressure/oxygen and fatigue on high-altitude flights. Importantly, we combined biosensor information with frequent medical measurements and made two important observations: First, wearable devices were useful in identification of early signs of Lyme disease and inflammatory responses; we used this information to develop a personalized, activity-based normalization framework to identify abnormal physiological signals from longitudinal data for facile disease detection. Second, wearables distinguish physiological differences between insulin-sensitive and -resistant individuals. Overall, these results indicate that portable biosensors provide useful information for monitoring personal activities and physiology and are likely to play an important role in managing health and enabling affordable health care access to groups traditionally limited by socioeconomic class or remote geography.</p></div

    Exposure to radiation in daily life.

    No full text
    <p>Bar plot (upper panel: bars in blue) showing the amount of radiation that Participant #1 exposed to over a 25-d time window. Bar plot (lower panel: bars in magenta) showing the time that Participant #1 spent in airplane flights over the same time period. The maximum cruising altitude of each flight was labeled in the zoomed view of the bar plots. Asterisk represents the amount of radiation monitored during the airport carry-on luggage check (range 0.027 to 0.031 mRem). Other events that resulted in relatively high radiation are also labeled in the figure.</p

    SpO<sub>2</sub> measurements during flight.

    No full text
    <p>(A) Example of a flight with continuous SpO<sub>2</sub> measurements (blue) taken using a Masimo finger device. Altitude recorded using FlightAware (green). (B) Heat map showing distribution of SpO<sub>2</sub> measurements recorded using a forehead Scanadu device at different flight stages: before takeoff, ascending, cruising, descending, and on ground post flight. (C) SpO<sub>2</sub> levels recorded using iHealth-finger device during 2-h automobile ride over a mountain. Average measurements and standard error measured over a 15-min window (Blue). Altitude recorded from sign markers or town elevations and/or using DraftLogic website. (D) Distribution of SpO<sub>2</sub> measurements taken from 18 individuals at cruising altitude (blue) versus on ground (green). (E) Distribution of SpO<sub>2</sub> measurements after the participant reported feeling alert (red) or tired (cyan). (Upper panel) Measurements from nonflying days. (Lower panel) Measurements from flying days. The significance of the difference between the two distributions was assessed by two-sample Kolmogorov–Smirnov test. (F) Scatterplot of response time and SpO<sub>2</sub> level recorded during one flight. The data recorded during another flight are shown in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.2001402#pbio.2001402.s005" target="_blank">S5D Fig</a>. The response time was derived from the psychomotor vigilance test to objectively quantify the fatigue of the participant. Self-reported tired and alert states are labeled by cyan triangles and red dots, respectively. (G) (Upper panel) Example of a flight with continuous SpO<sub>2</sub> measurements (blue) taken using a Masimo finger device. Altitude recorded using FlightAware (green). Note the increase in SpO<sub>2</sub> level towards the end of the flight. (Lower panel) Sleepiness recorded by Basis device. Magenta and cyan colors represent sleep and awake status, respectively. (H) A scatterplot of duration of time and the increase of SpO<sub>2</sub> in the last quarter. All data points were collected at altitudes higher than 35,000 feet. (I) Empirical cumulative distribution function plot of SpO<sub>2</sub> levels >7 h after takeoff (red) versus <2 h after takeoff (blue). All the data points were recorded at altitudes higher than 35,000 feet (<i>p</i> < 1e-307; two-sample Kolmogorov–Smirnov test).</p

    Circadian and diurnal patterns in physiological parameters.

    No full text
    <p>Participant #1 hourly summaries in (A) sleep, (B) HRs, (C) skin temperature, and (D) steps as measured using the Basis Peak device over 71 nontravel d. (E) Summaries of 43-person cohort for daily HR and skin temperature from all data and (F) differences in resting (fewer than five steps) nighttime and daytime HRs (Note: one person did not have nighttime measurements and is not included) and skin temperature. (G) Daily activity plots for 43 individuals. Based on number of peaks in the curves, four general patterns of activity behavior are evident. The plots in Fig 2G were aligned according to the first increase in activity.</p
    corecore